Shuttle Pharmaceuticals Holdings, Inc. — Form D

Shuttle Pharmaceuticals Holdings, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-15. The offering totals $500K, of which $125K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
William AdkinsDirectorRockville, MD
Milton BrownExecutive OfficerGaithersburg, MD
Peter DritschilloExecutive OfficerRockville, MD
Yuying LiangRelated PersonGAITHERSBURG, MD
Christopher CooperDirectorGAITHERSBURG, MD
Christopher CooperExecutive OfficerGAITHERSBURG, MD
Christopher CooperRelated PersonGAITHERSBURG, MD
Tyvin RichExecutive OfficerGaithersburg, MD
Adam ChambersDirectorGAITHERSBURG, MD
Adam ChambersRelated PersonGAITHERSBURG, MD
Mira JungExecutive OfficerGaithersburg, MD
Angel LirianoDirectorGAITHERSBURG, MD
Angel LirianoRelated PersonGAITHERSBURG, MD
Sachin PathigodaDirectorGaithersburg, MD
George ScorsisDirectorGAITHERSBURG, MD
George ScorsisRelated PersonGAITHERSBURG, MD
Timothy LorberExecutive OfficerGaithersburg, MD
Oleh NabytDirectorGaithersburg, MD
George ScorcisDirectorGaithersburg, MD
Steven RichardsDirectorGaithersburg, MD
Joseph TungDirectorGaithersburg, MD
Peter DritschiloDirectorGaithersburg, MD
Peter DritschiloExecutive OfficerGaithersburg, MD
Joshua SchaferDirectorGaithersburg, MD
Chris SenanayakeDirectorGaithersburg, MD

Other filings by this issuer (8)

FiledFormOfferingSold
2026-05-15D$10.0M$10.0M
2025-11-07D$2.5M$2.5M
2025-06-26D$4.3M$4.3M
2024-10-25D$1.3M$790K
2023-01-20D$4.0M$4.0M
2022-02-22D$2.0M$365K
2022-01-04D$500K$500K
2019-01-31D—$913K

More